TECHWIRE 30
(CIX: WRAL30)  1,126.86  up arrow+2.81  (0.25 %)  Updated: 12:56 PM EST, Dec 19 2014
(NQ: Apple)  112.48  down arrow-0.17  (-0.15 %)  Updated: 12:57 PM EST, Dec 19 2014
(NY: QUINTILES)  59.74  up arrow+0.36  (0.61 %)  Updated: 12:57 PM EST, Dec 19 2014
(OP: BASF SE)  84.69  down arrow-2.01  (-2.31 %)  Updated: 12:54 PM EST, Dec 19 2014
(NQ: BioCryst)  11.08  down arrow-0.01  (-0.05 %)  Updated: 12:56 PM EST, Dec 19 2014
(NQ: BioDelivery)  13.68  up arrow+0.62  (4.71 %)  Updated: 12:56 PM EST, Dec 19 2014
(NQ: CEMP)  20.58  up arrow+0.07  (0.32 %)  Updated: 12:57 PM EST, Dec 19 2014
(NQ: Cisco Systems)  27.70  up arrow+0.05  (0.18 %)  Updated: 12:56 PM EST, Dec 19 2014
(NQ: Cree)  31.09  up arrow+0.19  (0.61 %)  Updated: 12:56 PM EST, Dec 19 2014
(NQ: DARA)  0.85  up arrow+0.01  (1.32 %)  Updated: 12:56 PM EST, Dec 19 2014
(NY: EMC CORPORATION)  30.12  up arrow+0.17  (0.56 %)  Updated: 12:56 PM EST, Dec 19 2014
(NQ: Extreme Networks)  3.39  up arrow+0.04  (1.19 %)  Updated: 12:55 PM EST, Dec 19 2014
(NQ: FB)  79.61  up arrow+1.21  (1.54 %)  Updated: 12:57 PM EST, Dec 19 2014
(NY: GLAXOSMITHKLINE)  43.38  up arrow+0.09  (0.21 %)  Updated: 12:56 PM EST, Dec 19 2014
(NQ: GOOG)  510.43  down arrow-0.67  (-0.13 %)  Updated: 12:57 PM EST, Dec 19 2014
(NY: IBM)  158.56  up arrow+0.88  (0.56 %)  Updated: 12:56 PM EST, Dec 19 2014
(NY: LH)  105.81  down arrow-0.63  (-0.59 %)  Updated: 12:56 PM EST, Dec 19 2014
(OP: Lenovo Group)  26.17  up arrow+0.61  (2.39 %)  Updated: 12:47 PM EST, Dec 19 2014
(NY: MRK)  59.31  up arrow+0.33  (0.56 %)  Updated: 12:57 PM EST, Dec 19 2014
(NQ: Microsoft Corp)  47.80  up arrow+0.28  (0.58 %)  Updated: 12:57 PM EST, Dec 19 2014
(NQ: NTAP)  43.24  up arrow+0.52  (1.22 %)  Updated: 12:57 PM EST, Dec 19 2014
(NY: NOVARTIS AG)  94.57    (0 %)  Updated: 12:56 PM EST, Dec 19 2014
(OP: Novozymes A/S)  43.11  down arrow-0.32  (-0.73 %)  Updated: 12:16 PM EST, Dec 19 2014
(NY: PFIZER)  31.98  up arrow+0.01  (0.03 %)  Updated: 12:57 PM EST, Dec 19 2014
(NQ: Pozen)  8.08  up arrow+0.18  (2.28 %)  Updated: 12:56 PM EST, Dec 19 2014
(NY: RED HAT)  67.77  up arrow+6.27  (10.2 %)  Updated: 12:57 PM EST, Dec 19 2014
(NQ: BBRY)  9.96  down arrow-0.11  (-1.09 %)  Updated: 12:56 PM EST, Dec 19 2014
(NQ: Salix)  118.40  down arrow-0.05  (-0.04 %)  Updated: 12:56 PM EST, Dec 19 2014
(NQ: SQI)  14.96  down arrow-0.1  (-0.66 %)  Updated: 12:56 PM EST, Dec 19 2014

Posts tagged “NCBIO”

February 28

Premium Lock FDA commissioner delivers a life science innovation pep talk

"Innovation isn't important simply because it creates something new - it's only important if what it creates makes a meaningful and positive difference in people's lives," says FDA Commissioner Dr. Margaret Hamburg.

VIPs on stage at CED conference VIPs on stage at CED conference

Updated February 11

Premium Lock CED picks five startups to present at Life Science Conference

CED BioKier, CanDiag, Improved Patient Outcomes, KinoDyn, and Nova Synthetix will each get a chance to pitch potential investors during the "Innovation Showcase" on Feb. 26.

February 11, 2013

Premium Lock LabCorp to lead Venture Day at CED Life Science conference

LabCorp, the global lab testing firm based in Burlington, and its Chief Executive Officer David King are the host for "Venture Day" at the CED's annual life science conference.

CED Life Science conference CED Life Science conference

January 3, 2013

Premium Lock Nobel Prize winner headlines CED Life Science Conference program

Dr. Jack Szostak, a 2009 Nobel Prize winner and a professor of genetics at Harvard, headlines the program for the 22nd CED Life Science Conference next month.

CED Life Science Conference CED Life Science Conference

June 14, 2012

Premium Lock N.C. biotech sector to have big 'footprint' at BIO event

The N.C. Biotechnology Center and other representatives for the state's biotech industry will have a new 3,000 square foot pavillion at the BIO International Convention.

North Carolina's new 3,000 square foot pavilion North Carolina's new 3,000 square foot pavilion

Updated December 22, 2011

Premium Lock Opinion: New life sciences cluster report presents skewed view of RTP's activities

RTP The Triangle is outstanding for life sciences whether reports on U.S. markets score it first, last or in the middle.

October 4, 2010

Premium Lock Sanofi-Aventis launches Genzyme takeover battle

Genzyme France’s Sanofi-Aventis on Monday launched an $18.5 billion hostile takeover attempt for Genzyme Corp., escalating the battle after the U.S. biotech company’s management twice rejected its offer.

Tags: NCBIO
February 21, 2010

Premium Lock CED’s 19th annual Biotech Conference opens Monday in Raleigh

CED Biotech Conference One-on-one partnership meetings are among the event’s highlights. Former Embrex executive will receive top life science honor.

Updated November 16, 2009

Premium Lock Addrenex being bought by Sciele

Addrenex The Atlanta-based buyer will pay about $29 million for developmental drugs it didn't already own.

Updated May 11, 2009

Premium Lock CED’s Medtech conference to highlight emerging medical device industry in N.C.

CED to showcase Medtech In a state where biotech dominates life science headlines, device company execs and CED band together to raise the industry profile. They also want other companies to become more aware of N.C.’s advantages as a home for emerging ventures.

Updated April 17, 2009

Premium Lock ‘We Work for Health’ – New group seeks to spark medical innovation in N.C.

Sam Taylor Biotech, pharmaceutical and medical science firms across the state form ‘one of the biggest life science engines in the country,’ NCBIO executive tells group at kickoff event. He cautions against changes that would ‘undermine’ that engine.

Tags: NCBIO, GSK
Updated March 18, 2009

Premium Lock Biotech Center provides $2.5M to launch medical device center

 Advanced Medical Technology Center for Innovation is set to launch in May. NCBIO led research effort for project. Search for director is under way.

Updated March 16, 2009

Premium Lock Want more jobs? Governor could spark wave of new ventures with a 'Founder’s Credit'

 Governor plans "Founder's Credit" Gov. Bev Perdue sends a lightning bolt through ranks of investors, entrepreneurs with word she will include tax breaks for startups in her budget.

Tags: NCBIO, CED, NCTA
Updated March 16, 2009

Premium Lock Perdue’s ‘Founder’s Credit’ could spark entrepreneurs, investors to launch new businesses

 Entrepreneurs, investors and three of state’s top business organizations express support for N.C. governor’s proposal to ‘exclude’ investments in certain startup companies from capital gains. Current law ‘encourages most successful entrepreneurs to leave the state when they have an exit from their company,’ says one serial entrepreneur.

Updated March 13, 2009

Premium Lock Perdue's 'Founder's Credit' could spark entrepreneurs, investors

'Founder's Credit' is part of governor's budget plan Entrepreneurs, investors and three of state’s top business organizations express support for N.C. governor’s proposal to ‘exclude’ investments in certain startup companies from capital gains. Current law ‘encourages most successful entrepreneurs to leave the state when they have an exit from their company,’ says one serial entrepreneur.

April 14, 2008

Premium Lock N.C. Biotech Training Group Changes Name

NCBIOIMPACT NCBIOIMPACT is new name for consortium involved in biotech worker training programs.

January 8, 2008

Premium Lock NCBIO-Led Group Receives $100,000 Grant for Emerging Technology Effort

NCBIO N.C. Biotech Center funds initial planning for a Center of Innovation focused on medical devices, technology. Grant could lead to additional $2.5M in funding.

Updated October 22, 2007

Premium Lock Various Health Groups Ask Congress to Restore SBIR Grants for Venture-Backed Firms; NC BIO Adds Support

BIO logo Update: Legislation passed in House would restore eligibility of startups to pursue government funding. NC BIO, meanwhile, says it also backs bill.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith

OUR INSIDERS

Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Scroll